Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.
about
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast DifferentiationInhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis.microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Bone resorption facilitates osteoblastic bone metastatic colonization by cooperation of insulin-like growth factor and hypoxia.The role of the insulin-like growth factor-1 system in breast cancerExtracellular molecules involved in cancer cell invasionIsoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.The role of the bone microenvironment in skeletal metastasis.The SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression.The Inhibitory Effects of Forsythia Koreana Extracts on the Metastatic Ability of Breast Cancer Cells and Bone Resorption by Osteoclasts.Role of RANKL/RANK in primary and secondary breast cancer.Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.Targeting RANKL in breast cancer: bone metastasis and beyond.Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis.Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapyNew therapeutic targets for cancer bone metastasisTargeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.Diverse roles of miR-335 in development and progression of cancers.Biochemical Changes in the Niche Following Tumor Cell Invasion.Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivoHuman antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity.Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.Cellular and Molecular Mediators of Bone Metastatic Lesions.
P2860
Q26783571-660DA6AB-25E4-49E2-B659-8D343395EC98Q31138811-42A510EE-3F3B-44AF-97CC-E72EF8F31F7DQ34257789-0E863A06-AC10-4B53-AE35-CCB8F36F408CQ34699785-A9847D48-B4DE-47F0-9290-96DD3F4D6BCCQ35051528-12C92A8B-84A1-4C4A-9D2D-BB9BC7582226Q35105295-F903D0BE-15C6-475D-88B8-E13A6BB91EDBQ35237503-48F8C25A-49FF-489F-95D1-77901F2CC0EFQ36426121-5B805478-1775-40FC-8C12-EEDF739B249DQ36491430-634E60D1-9D2F-4681-841D-1E01C85A753DQ36492336-2D11D22D-20DB-4F2A-8889-217F75BC2FDBQ37066418-963B0354-FF93-479D-8BAC-FE8756703DB2Q37241255-0E280C77-AD3B-4C06-9184-A7530EE11E7AQ37334160-1805697D-6CCC-46AD-A11E-33E653CDA68BQ37648868-2A99C681-83E4-4995-8730-B3B888DBBCECQ37660315-6B24DCD7-726D-4468-A094-C1A82F9FC545Q38081245-DC28AE2D-7E7D-49F7-AA90-FB96129A8101Q38155200-C7780722-B06C-4120-8E4B-BC786CF5264CQ38177688-2148C375-7615-4624-87B9-E773E9BCEB4FQ38473066-3C78A67E-3810-4DFB-9834-B43E215A90FAQ38700342-862694DA-AE98-4AE4-A7A3-015488375950Q38818910-A979D6EA-F218-4DD2-921F-09EA279060EEQ38834735-796441E4-2791-476C-AC52-DBFA6B904CA5Q38975536-B23678CA-2CEE-40D2-ACF4-BDFFBCD32320Q39041143-77054EF5-7703-441C-BC10-E3E28B7116F2Q41336735-A9E7537F-20B5-4DF2-8FC1-FF62581C1A93Q41548165-184B9490-7F5A-4B3D-98A3-C6902942BE81Q42248557-D5E2DFDD-1DC0-495B-A7F7-F50440C687FCQ50437697-ACC1A266-19FD-4180-BBA7-CFF88F61DAECQ53197894-66BDD6A6-27E2-41AE-9B8B-1561F1E52855Q55434830-1486990C-7D50-4E43-8531-3950F7D03692Q55474543-E902DE14-5EF0-46A1-B8C2-6B32C91C6C13Q55643144-2323CA54-C058-402B-A8AF-3DAF7D4D207C
P2860
Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@ast
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@en
type
label
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@ast
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@en
prefLabel
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@ast
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@en
P2093
P2860
P1433
P1476
Bone-derived IGF mediates cros ...... ncer cells in bony metastases.
@en
P2093
Akira Myoui
Akira Sasaki
Clifford J Rosen
Gregory R Mundy
Hideki Yoshikawa
Kenji Hata
Nobuyuki Hashimoto
Toru Hiraga
Toshiyuki Yoneda
Yoshihiro Morita
P2860
P304
P356
10.1158/0008-5472.CAN-11-3061
P407
P577
2012-06-27T00:00:00Z